Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
PaperCitations, authors & open-access status
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 660 citations, 2018 year and green oa status.
660
Citations
2018
Year
green
OA Status